7 Non-Prescription Options Men Are Using for Erection Support in 2026

The strongest evidence base of any non-pharmaceutical intervention for erectile dysfunction. A 2019 randomized controlled trial in BJU International found that structured pelvic floor muscle training restored normal erectile function in 40% of men with ED, with another 35% showing significant improvement — without any medication, device, or supplement.

The mechanism is direct: the ischiocavernosus and bulbocavernosus muscles compress the crura of the corpus cavernosum, driving blood pressure and maintaining venous occlusion. Strengthening these muscles addresses the physical mechanism of erection quality at its source.

Best for: Men with venous-dominant ED (achieving erections but losing them during activity). Less effective for arterial-dominant cases.

Timeline: 6–12 weeks before significant improvement. Effects are durable — structural muscle changes don't disappear when you stop.

Cost: Free. The protocol can be done without any equipment or professional instruction, though a pelvic floor physiotherapist can provide biofeedback if self-identification of the muscles proves difficult.

Constriction rings address venous leak mechanically by creating external resistance at the penile base, supplementing the natural venous occlusion mechanism that may have weakened with age or structural changes. The ring slows venous outflow, maintaining intracavernosal pressure under the dynamic demands of sex.

Products like BullRing ($19.80 for 4 sizes) use anatomical multi-point pressure rather than simple circular compression. The multi-point design maintains contact across the full base circumference while accommodating variation in anatomy and erection state.

Best for: Men who achieve erections normally but lose firmness mid-session. If achieving initial erection is the primary difficulty, a constriction ring alone won't address the root cause — that's arterial, not venous.

Timeline: Immediate effect. Works the first time it's used correctly, unlike exercises or supplements that require weeks of accumulation.

Limitations: Not a fix for arterial insufficiency or nerve issues. Should not be worn for more than 30 minutes. Men with blood clotting disorders or Peyronie's disease should consult a physician before use.

FDA-cleared and backed by decades of clinical use, vacuum erection devices are one of the most evidence-supported treatments for ED. They work by creating a vacuum seal around the penis, drawing blood in mechanically. A constriction ring placed at the base then traps the blood and maintains the erection.

The evidence is particularly strong in post-prostatectomy rehabilitation, where VED use in the months following surgery is associated with better long-term erectile function recovery. For men with severe arterial insufficiency or nerve damage, VEDs can produce functional erections when no other non-surgical option reliably does.

Best for: Post-surgical ED (especially post-prostatectomy); severe organic ED where PDE5 inhibitors are contraindicated or ineffective.

Limitations: The process of using a VED is not spontaneous — it requires interrupting the sexual encounter. Some men find the device-assisted erection feels different (typically cooler, without the fullness of a naturally-achieved one). High-quality devices range from $80 to $300.

Nitric oxide (NO) is the signal molecule that triggers penile arterial dilation. L-arginine is the amino acid precursor to NO; L-citrulline converts to arginine more efficiently in the kidney, making it a better oral supplement option. Several randomized trials have shown modest but real improvements in erectile function scores with high-dose supplementation (3–5g/day of L-citrulline).

The effect is most pronounced in men with mild vascular insufficiency. For men with significant arterial disease, supplemental amino acids can't overcome the structural limitations of compromised vessels.

Best for: Mild vascular ED; men who want to support the NO pathway through diet rather than medication.

Limitations: Effect size is modest compared to PDE5 inhibitors. Requires consistent daily supplementation, not as-needed use. Takes weeks to show results.

Low-intensity extracorporeal shockwave therapy (Li-ESWT) uses acoustic waves delivered to penile tissue with the proposed mechanism of stimulating neovascularization — the growth of new blood vessels. The theory is that new vessel formation improves arterial supply to the corpus cavernosum.

The evidence is promising but still developing. Multiple small RCTs have shown improvement in erectile function scores. A 2017 meta-analysis in European Urology found statistically significant improvements across 7 controlled trials. However, study quality is variable, protocols differ between providers, and long-term durability data is limited.

Best for: Men with mild to moderate vasculogenic ED who haven't responded to other interventions and are willing to invest in a multi-session clinical treatment.

Limitations: Requires 6–12 clinic sessions ($150–400 each, rarely covered by insurance). Consumer devices marketed for home use are generally lower intensity than clinical devices and have almost no supporting evidence.

Testosterone replacement therapy (TRT) is one of the most prescribed interventions for male sexual dysfunction, and one of the most frequently misprescribed. It is effective — for men with clinically confirmed low testosterone. For men with testosterone within the normal range, adding exogenous testosterone produces no improvement in erectile function, and suppresses natural production in the process.

The threshold that most practitioners use for clinically low T is total testosterone below 300 ng/dL, combined with symptoms. Some endocrinologists focus on free testosterone, which can be low even when total T appears normal due to elevated SHBG.

Best for: Confirmed hypogonadism. Not useful for eugonadal men regardless of how much lower their T is than their personal peak.

Limitations: Requires blood testing to establish candidacy. Suppresses natural testosterone production while on treatment. Long-term implications for fertility. Should be managed by a physician.

Red and near-infrared light therapy applied to penile tissue has received attention based on the hypothesis that photobiomodulation increases nitric oxide production in endothelial cells. There is some early-stage research suggesting effects on NO pathways in vascular tissue generally.

Specific to erectile function, the evidence is limited to a small number of studies, some with design weaknesses. A 2019 pilot study showed positive trends but was underpowered. There is not yet sufficient controlled trial data to make a strong recommendation.

Best for: Men willing to experiment with low-risk interventions while evidence develops.

Limitations: Inconclusive evidence. Consumer devices vary significantly in wavelength and intensity. The field is early enough that anyone citing confident claims about effectiveness is ahead of the data.